Fundraising Fox
/Companies
Sign in

Turnstone Biologics

New York, US · Founded 2018 · Delaware corporation · 8 known investors

Find your way into Turnstone Biologics

Biotech

Founders & leadership

MBMichael Burgess
Michael BurgessExecutive
JM
Jose Manuel OteroNamed on SEC filing
RGRobert Gould
Robert GouldDirector2018–2025Executive Officer, Director at Fulcrum Therapeutics
JHJane Henderson
Jane HendersonChief Financial Officer2018–2020Executive Officer at Adagio Therapeutics
SL
Stefan LarsonNamed on SEC filing
PM
Patrick MachadoNamed on SEC filing
SF
Sammy FarahNamed on SEC filing

Board

BBBrad Bolzon
Brad BolzonBoard directorChairman, Managing Director at Versant Ventures
JDJerel Davis
Jerel DavisBoard directorManaging Director at Versant Ventures
RG
Rishi GuptaBoard directorPartner at OrbiMed

Investors · 8

F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M

How we know: F-Prime Capital's portfolio page · Not right? Tell us

FACIT (Fight Against Cancer Innovation Trust)listed by FACIT (Fight Against Cancer Innovation Trust)Toronto · $1.1M

How we know: FACIT (Fight Against Cancer Innovation Trust)'s portfolio page · Not right? Tell us

Foothill Ventureslisted by Foothill VenturesLos Altos · $100K – $10M

How we know: Foothill Ventures's portfolio page · Not right? Tell us

Venture Ontariolisted by Venture OntarioToronto

How we know: Venture Ontario's portfolio page · Not right? Tell us

OrbiMedreportedNew York · $1M – $75M

How we know: the VCSheet dataset · Not right? Tell us

Point72reportedStamford

How we know: funding news · Not right? Tell us

Versant VenturesreportedSan Francisco · $250K – $5Mvia Brad Bolzon · board

How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$122.1M disclosed across 2 rounds · 2019–2021

▶$80MraisedJul 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick MachadoDirector
  • Maura CampbellExecutive Officer
  • Stefan LarsonDirector
  • Robert GouldDirector
  • Jose Manuel OteroExecutive Officer
  • Jerel DavisDirector
  • Michael BurgessExecutive Officer, Director
  • Sammy FarahExecutive Officer, Director
  • Rishi GuptaDirector
Offering amount
$80M
Amount sold
$80M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.1MraisedJan 2019 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brad BolzonDirector
  • Jose Manuel OteroExecutive Officer
  • Robert GouldDirector
  • Jerel DavisDirector
  • Jane HendersonExecutive Officer
  • Michael BurgessExecutive Officer
  • Stefan LarsonDirector
  • Patrick MachadoDirector
  • Rishi GuptaDirector
  • Sammy FarahExecutive Officer, Director
Offering amount
$42.1M
Amount sold
$42.1M
First sale
Jan 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Turnstone Biologics's investors?
Turnstone Biologics's investors include Brace Pharma, F-Prime Capital, FACIT (Fight Against Cancer Innovation Trust), Foothill Ventures, Venture Ontario, OrbiMed, Point72, Versant Ventures.
How much funding has Turnstone Biologics raised?
Turnstone Biologics has disclosed $122.1M raised across 2 rounds.
Where is Turnstone Biologics headquartered?
Turnstone Biologics is headquartered in New York, US.